These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17899230)

  • 1. Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia.
    Horn D; Neofytos D; Fishman J; Steinbach W; Anaisie E; Marr KA; Pfaller M; Olyaei A
    Eur J Clin Microbiol Infect Dis; 2007 Dec; 26(12):907-14. PubMed ID: 17899230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial management of candidemia at an academic medical center: evaluation of the IDSA guidelines.
    Patel M; Kunz DF; Trivedi VM; Jones MG; Moser SA; Baddley JW
    Diagn Microbiol Infect Dis; 2005 May; 52(1):29-34. PubMed ID: 15878439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines.
    Garey KW; Pai MP; Suda KJ; Turpin RS; Rege MD; Mingo DE; Bearden DT
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):919-27. PubMed ID: 17286303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single center's experience with Candida parapsilosis related long-term central venous access device infections: the port removal decision and its outcomes.
    Devrim I; Yaman Y; Demirağ B; Oymak Y; Cartı Ö; Özek G; Tulumoğlu S; Erdem T; Gamze G; Gözmen S; Güneş BT; Bayram N; Vergin C
    Pediatr Hematol Oncol; 2014 Aug; 31(5):435-41. PubMed ID: 24383767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing Adherence to the 2016 Infectious Diseases Society of America Guidelines for Candidemia in Cancer Patients.
    Lehmann DM; Cohen N; Lin IH; Alexander S; Kathuria R; Kerpelev M; Taur Y; Seo SK
    Open Forum Infect Dis; 2022 Dec; 9(12):ofac555. PubMed ID: 36540383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of candidemia and invasive candidiasis according to guidelines].
    Glöckner A
    Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory neonatal candidemia and high-dose micafungin pharmacotherapy.
    Natarajan G; Lulic-Botica M; Aranda JV
    J Perinatol; 2009 Nov; 29(11):738-43. PubMed ID: 19776753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
    DiNubile MJ; Lupinacci RJ; Strohmaier KM; Sable CA; Kartsonis NA
    J Crit Care; 2007 Sep; 22(3):237-44. PubMed ID: 17869975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
    Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
    Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Echinocandins and the 2009 guidelines for treatment of candidiasis].
    Melo LH
    Drugs Today (Barc); 2010 Mar; 46 Suppl B():7-12. PubMed ID: 20407663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship.
    Mellinghoff SC; Hartmann P; Cornely FB; Knauth L; Köhler F; Köhler P; Krause C; Kronenberg C; Kranz SL; Menon V; Müller H; Naendrup JH; Pützfeld S; Ronge A; Rutz J; Seidel D; Wisplinghoff H; Cornely OA
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1563-1571. PubMed ID: 29948362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
    Horn DL; Fishman JA; Steinbach WJ; Anaissie EJ; Marr KA; Olyaei AJ; Pfaller MA; Weiss MA; Webster KM; Neofytos D
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):407-14. PubMed ID: 17888614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
    Pappas PG; Kauffman CA; Andes DR; Clancy CJ; Marr KA; Ostrosky-Zeichner L; Reboli AC; Schuster MG; Vazquez JA; Walsh TJ; Zaoutis TE; Sobel JD
    Clin Infect Dis; 2016 Feb; 62(4):e1-50. PubMed ID: 26679628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients].
    Groll AH; Ritter J
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S37-66. PubMed ID: 16288352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.